AGHEMO, ALESSIO MICHELE
AGHEMO, ALESSIO MICHELE
Universita' degli Studi di MILANO
A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients
2012 R. D'Ambrosio, A. Aghemo, M. Rumi, G. Ronchi, M.F. Donato, V. Paradis, M. Colombo, P. Bedossa
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review
2014 F. Fabrizi, A. Aghemo, G.B. Fogazzi, G. Moroni, P. Passerini, R. D'Ambrosio, P. Messa
Allelic inhibition of displacement activity : a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms
2013 E. Galmozzi, F. Facchetti, E. Degasperi, A. Aghemo, P. Lampertico
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C
2014 A. Andriulli, A. Nardi, V. Di Marco, A.M. Ippolito, C. Gavrila, A. Aghemo, D. Di Paolo, G. Squadrito, E. Grassi, V. Calvaruso, M.R. Valvano, G. Brancaccio, A. Craxi, M. Angelico, G. Raimondo, M. Milella, F. Morisco, G. Fattovich, M. Felder, A. Smedile, M. Fasano, T. Santantonio, P. Gatti, N. Nicolaandriulli, P. Tundo, M. Barone, R. Cozzolongo, N. Giovanna D'Andrea, G. Mazzella
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis
2008 A. Aghemo, L. Ronzoni, M. Rumi, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M.D. Cappellini, M. Colombo
Anti-TNF drugs in patients with hepatitis B or C virus infection : safety and clinical management
2012 M. Viganò, E. Degasperi, A. Aghemo, P. Lampertico, M. Colombo
Assessing long-term treatment efficacy in chronic hepatitis B and C : Between evidence and common sense
2012 A. Aghemo, P. Lampertico, M. Colombo
Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis C
2015 R. D'Ambrosio, A. Aghemo, M. Colombo
Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication?
2015 M.F. Donato, S. Monico, F. Malinverno, A. Aghemo, M. Maggioni, P. Reggiani, M. Colombo
Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection
2016 E. Degasperi, F. Caprioli, O. El Sherif, D. Back, M. Colombo, A. Aghemo
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients
2013 A. Aghemo, E. Degasperi, M.G. Rumi, E. Galmozzi, L. Valenti, R. De Francesco, S. De Nicola, C. Cheroni, E. Grassi, M. Colombo
Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection
2014 J. Vermehren, A. Aghemo, K. Falconer, S. Susser, G. Lunghi, S. Zeuzem, M. Colombo, O. Weiland, C. Sarrazin
Commentary : Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C
2013 A. Aghemo, P. Lampertico
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C
2012 M. Rumi, A.M. Aghemo, G.M. Prati
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort
2020 A. Soria, M. Fava, D.P. Bernasconi, G. Lapadula, E. Colella, M.G. Valsecchi, G.M. Migliorino, R. D'Ambrosio, S. Landonio, M. Schiavini, A. Spinetti, C. Carriero, E. Degasperi, G. Cologni, F. Gatti, P. Vigano, H. Hasson, C. Uberti-Foppa, L. Pasulo, C. Baiguera, R. Rossotti, M. Vinci, M. Puoti, A. Giorgini, B. Menzaghi, A. Lombardi, A. Pan, A. Aghemo, P.A. Grossi, R. Boldizzoni, S. Colombo, M. Vigano, M.G. Rumi, P. Del Poggio, L. Valenti, O. Giglio, A. De Bona, A. d'Arminio Monforte, A. Colombo, O. Spinelli, M.G. Pigozzi, C. Molteni, P. Bonfanti, N. Terreni, P. Perini, A. Capretti, D. Bella, C. Liani, S. Polo, G. Aimo, L. Pagnucco, S. Bhoori, R. Centenaro, M. Graffeo, A. Ciaccio, E. Dionigi, S. Lazzaroni, I. Carderi, M. Di Marco, G. Rizzardini, F. Noventa, P. Lampertico, S. Fagiuoli
Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis
2013 M. Iavarone, M.A. Manini, A. Sangiovanni, M. Fraquelli, L.V. Forzenigo, L. Di Tommaso, A. Aghemo, M. Roncalli, G. Ronchi, M. Colombo
COVID-19 and liver disease
2020 J. Sun, A. Aghemo, A. Forner, L. Valenti
COVID-19 and the liver: A 2021 update
2021 C.W. Spearman, A. Aghemo, L. Valenti, M.W. Sonderup
Daclatasvir : a team player rather than a prima donna in the treatment of hepatitis C
2015 A. Aghemo, R. De Francesco
Daclatasvir for the treatment of chronic hepatitis C
2015 E. Degasperi, A. Aghemo, M. Colombo